Dare Bioscience (DARE) Competitors $2.52 +0.13 (+5.44%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$2.48 -0.04 (-1.79%) As of 07/11/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DARE vs. EXOZ, CABA, JMAC, IGMS, PLRX, ZURA, EPIX, QNCX, SRZN, and INCRShould you be buying Dare Bioscience stock or one of its competitors? The main competitors of Dare Bioscience include eXoZymes (EXOZ), Cabaletta Bio (CABA), Maxpro Capital Acquisition (JMAC), IGM Biosciences (IGMS), Pliant Therapeutics (PLRX), Zura Bio (ZURA), ESSA Pharma (EPIX), Quince Therapeutics (QNCX), Surrozen (SRZN), and InterCure (INCR). These companies are all part of the "pharmaceutical products" industry. Dare Bioscience vs. Its Competitors eXoZymes Cabaletta Bio Maxpro Capital Acquisition IGM Biosciences Pliant Therapeutics Zura Bio ESSA Pharma Quince Therapeutics Surrozen InterCure eXoZymes (NASDAQ:EXOZ) and Dare Bioscience (NASDAQ:DARE) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, media sentiment, analyst recommendations and institutional ownership. Which has preferable valuation & earnings, EXOZ or DARE? Dare Bioscience has higher revenue and earnings than eXoZymes. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioeXoZymesN/AN/A-$5.86MN/AN/ADare Bioscience$10K2,230.20-$4.05M-$0.17-14.82 Is EXOZ or DARE more profitable? Company Net Margins Return on Equity Return on Assets eXoZymesN/A N/A N/A Dare Bioscience N/A N/A -8.14% Do institutionals and insiders hold more shares of EXOZ or DARE? 6.7% of Dare Bioscience shares are owned by institutional investors. 72.4% of eXoZymes shares are owned by company insiders. Comparatively, 4.0% of Dare Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media refer more to EXOZ or DARE? In the previous week, Dare Bioscience had 2 more articles in the media than eXoZymes. MarketBeat recorded 3 mentions for Dare Bioscience and 1 mentions for eXoZymes. eXoZymes' average media sentiment score of 1.87 beat Dare Bioscience's score of 1.21 indicating that eXoZymes is being referred to more favorably in the media. Company Overall Sentiment eXoZymes Very Positive Dare Bioscience Positive Do analysts rate EXOZ or DARE? Dare Bioscience has a consensus target price of $12.00, suggesting a potential upside of 376.19%. Given Dare Bioscience's stronger consensus rating and higher possible upside, analysts plainly believe Dare Bioscience is more favorable than eXoZymes.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score eXoZymes 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Dare Bioscience 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 SummaryDare Bioscience beats eXoZymes on 7 of the 10 factors compared between the two stocks. Get Dare Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for DARE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DARE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DARE vs. The Competition Export to ExcelMetricDare BioscienceMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$22.26M$2.94B$5.56B$9.11BDividend YieldN/A2.42%5.06%4.01%P/E Ratio-14.8220.8528.2620.26Price / Sales2,230.20300.55435.95101.33Price / CashN/A42.1137.1257.67Price / Book-3.657.638.045.49Net Income-$4.05M-$55.05M$3.19B$250.45M7 Day Performance5.00%8.43%3.62%4.78%1 Month Performance-16.83%8.14%5.98%9.58%1 Year Performance-31.52%1.62%29.39%16.41% Dare Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DAREDare Bioscience1.7451 of 5 stars$2.52+5.4%$12.00+376.2%-31.5%$22.26M$10K-14.8230News CoveragePositive NewsGap DownHigh Trading VolumeEXOZeXoZymesN/A$10.18+2.7%N/AN/A$82.93M$70K0.0029Positive NewsGap DownCABACabaletta Bio2.6192 of 5 stars$1.49-8.6%$14.43+868.4%-78.9%$82.71MN/A-0.5950News CoveragePositive NewsGap UpJMACMaxpro Capital AcquisitionN/A$6.14-6.4%N/A+2,596.7%$82.45MN/A0.002,021News CoverageIGMSIGM Biosciences4.6754 of 5 stars$1.35-0.7%$5.50+307.4%-85.9%$81.29M$2.68M-0.41190Positive NewsPLRXPliant Therapeutics4.496 of 5 stars$1.18-6.3%$13.31+1,028.2%-88.9%$77.35M$1.58M-0.3390News CoverageZURAZura Bio2.9069 of 5 stars$1.10-2.7%$14.33+1,203.0%-64.7%$77.26MN/A-1.573News CoveragePositive NewsGap UpEPIXESSA Pharma1.9452 of 5 stars$1.70-2.3%$2.00+17.6%-68.2%$77.24MN/A-2.7050QNCXQuince Therapeutics3.3301 of 5 stars$1.63+1.2%$8.00+390.8%+133.9%$73.21MN/A-1.1760News CoverageSRZNSurrozen2.7807 of 5 stars$8.35-0.1%$38.50+361.1%-7.3%$71.58M$10.65M-0.3380Gap DownINCRInterCure0.6718 of 5 stars$1.50-3.8%N/A-37.3%$71.09M$238.85M0.00350High Trading Volume Related Companies and Tools Related Companies eXoZymes Alternatives Cabaletta Bio Alternatives Maxpro Capital Acquisition Alternatives IGM Biosciences Alternatives Pliant Therapeutics Alternatives Zura Bio Alternatives ESSA Pharma Alternatives Quince Therapeutics Alternatives Surrozen Alternatives InterCure Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DARE) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dare Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dare Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
